News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
556,390 Results
Type
Article (22500)
Company Profile (226)
Press Release (533655)
Multimedia
Podcasts (238)
Webinars (17)
Section
Business (187293)
Career Advice (1074)
Deals (28951)
Drug Delivery (106)
Drug Development (63278)
Employer Resources (145)
FDA (11568)
Job Trends (10745)
News (270656)
Policy (21797)
Tag
2027 BioMidwest Elite (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (997)
Academic (1)
Accelerated approval (37)
ADA (27)
Adcomms (17)
Allergies (125)
Alliances (38787)
ALS (145)
Alzheimer's disease (1262)
Antibody-drug conjugate (ADC) (367)
Approvals (11940)
Artificial intelligence (542)
ASCO (224)
Autoimmune disease (249)
Automation (39)
Bankruptcy (302)
Best Places to Work (7865)
BIO (80)
BIOSECURE Act (17)
Biosimilars (155)
Biotechnology (143)
Bladder cancer (154)
Brain cancer (43)
Breast cancer (576)
Cancer (4350)
Cardiovascular disease (323)
Career advice (935)
Career pathing (40)
CAR-T (238)
CDC (32)
Celiac Disease (2)
Cell therapy (704)
Cervical cancer (37)
Clinical research (55172)
Collaboration (1612)
Commercialization (3)
Company closure (6)
Compensation (1415)
Complete response letters (56)
COVID-19 (1925)
CRISPR (97)
C-suite (935)
Cystic fibrosis (104)
Data (6282)
Decentralized trials (2)
Denatured (96)
Depression (136)
Dermatology (63)
Diabetes (428)
Diagnostics (4901)
Digital health (41)
Diversity (13)
Diversity, equity & inclusion (42)
Drug discovery (258)
Drug pricing (101)
Drug shortages (14)
Duchenne muscular dystrophy (240)
Earnings (76900)
Editorial (56)
Employer branding (22)
Employer resources (121)
Events (97840)
Executive appointments (832)
FDA (14404)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (20)
Frontotemporal dementia (29)
Funding (1316)
Gene editing (192)
Generative AI (43)
Gene therapy (560)
GLP-1 (724)
Government (1992)
Grass and pollen (3)
Guidances (301)
Healthcare (10877)
Hematology (115)
HIV (60)
Huntington's disease (45)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (84)
Immunology and inflammation (206)
Immuno-oncology (77)
Indications (166)
Infectious disease (2169)
Inflammatory bowel disease (156)
Inflation Reduction Act (13)
Influenza (105)
Intellectual property (279)
Interviews (168)
IPO (13515)
IRA (27)
Job creations (3048)
Job search strategy (818)
JPM (57)
Kidney cancer (16)
Labor market (123)
Layoffs (369)
Leadership (25)
Legal (5960)
Liver cancer (64)
Longevity (27)
Lung cancer (602)
Lymphoma (291)
Machine learning (47)
Management (35)
Manufacturing (834)
Marketing (7)
MASH (162)
Medical device (9619)
Medtech (9754)
Mergers & acquisitions (16506)
Metabolic disorders (1105)
mRNA (215)
Multiple sclerosis (122)
NASH (12)
Neurodegenerative disease (333)
Neuropsychiatric disorders (65)
Neuroscience (2361)
Neurotech (1)
NextGen: Class of 2026 (4134)
Non-profit (1195)
Now hiring (78)
Obesity (470)
Opinion (215)
Ovarian cancer (171)
Pain (197)
Pancreatic cancer (231)
Parkinson's disease (248)
Partnered (26)
Patents (528)
Patient recruitment (551)
Peanut (40)
People (47014)
Pharmaceutical (44)
Pharmacy benefit managers (17)
Phase 1 (17869)
Phase 2 (24893)
Phase 3 (17292)
Pipeline (7595)
Policy (231)
Postmarket research (1730)
Preclinical (7513)
Press Release (59)
Prostate cancer (217)
Psychedelics (57)
Radiopharmaceuticals (247)
Rare diseases (851)
Real estate (4120)
Recruiting (55)
Regulatory (17717)
Reports (71)
Research institute (1031)
Resumes & cover letters (156)
Rett syndrome (42)
RNA editing (21)
RSV (57)
Schizophrenia (134)
Series A (254)
Series B (188)
Service/supplier (5)
Sickle cell disease (84)
Special edition (31)
Spinal muscular atrophy (107)
Sponsored (31)
Startups (2936)
State (1)
Stomach cancer (7)
Supply chain (80)
Tariffs (32)
The Weekly (139)
Vaccines (832)
Venture capital (112)
Weight loss (275)
Women's health (100)
Worklife (19)
Date
Last 7 days (319)
Last 30 days (1301)
Last 365 days (22438)
2026 (12890)
2025 (22573)
2024 (26965)
2023 (30483)
2022 (39888)
2021 (42871)
2020 (38309)
2019 (28116)
2018 (20860)
2017 (23201)
2016 (22629)
2015 (28149)
2014 (24734)
2013 (20703)
2012 (22774)
2011 (22807)
2010 (22384)
Location
Africa (542)
Alabama (76)
Alaska (4)
Arizona (303)
Arkansas (13)
Asia (26433)
Australia (4123)
California (12364)
Canada (3248)
China (850)
Colorado (496)
Connecticut (434)
Delaware (270)
Europe (45612)
Florida (1781)
Georgia (391)
Hawaii (3)
Idaho (53)
Illinois (828)
India (73)
Indiana (429)
Iowa (21)
Japan (439)
Kansas (116)
Kentucky (35)
Louisiana (30)
Maine (26)
Maryland (1254)
Massachusetts (8418)
Michigan (313)
Minnesota (640)
Mississippi (5)
Missouri (94)
Montana (26)
Nebraska (14)
Nevada (142)
New Hampshire (70)
New Jersey (2852)
New Mexico (28)
New York (2932)
North Carolina (1350)
North Dakota (5)
Northern California (6188)
Ohio (327)
Oklahoma (17)
Oregon (20)
Pennsylvania (2349)
Puerto Rico (25)
Rhode Island (35)
South America (708)
South Carolina (77)
South Dakota (1)
Southern California (5007)
Tennessee (128)
Texas (2041)
United States (40923)
Utah (395)
Vermont (1)
Virginia (176)
Washington D.C. (54)
Washington State (948)
West Virginia (2)
Wisconsin (94)
Wyoming (1)
556,390 Results for "takara bio usa inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Takara Bio USA, Inc. Announces the Retirement of Carol Lou, Appoints Andrew Farmer as President and CEO
July 9, 2026
·
4 min read
Press Releases
Takara Bio USA, Inc. to Showcase Instrument-Free Approach to Spatial Biology at Human Cell Atlas 2026 Meeting
June 16, 2026
·
4 min read
Press Releases
Takara Bio USA, Inc. Validates New Class of Spatial Technology with Benchmark Study for Cancer Research
April 20, 2026
·
3 min read
Press Releases
Takara Bio USA and Hamilton Company Partner to Automate NGS Library Preparation
March 30, 2026
·
3 min read
Press Releases
Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies
April 17, 2026
·
5 min read
Press Releases
Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026
February 26, 2026
·
3 min read
Business
Jumpcode Genomics and Takara Bio USA Announce Global Patent Partnership
Jumpcode Genomics and Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the companies have settled their patent dispute and have partnered to bring together their combined foundational IP in the field of targeted depletion of undesired transcripts such as ribosomal RNAs from NGS libraries using CRISPR-based technology.
June 13, 2024
·
3 min read
Biotech Bay
Takara Bio Launches First Commercial Dissolvable Microfluidic Lentiviral Transduction Enhancer
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market dissolvable microfluidic transduction enhancer that innovates in vitro lentivirus-mediated gene delivery techniques.
May 6, 2024
·
3 min read
Biotech Bay
Takara Bio USA Wins EU Opposition Hearing, Revoking Jumpcode Genomics’ NGS Library Enrichment Patent
Takara Bio USA, Inc. announced that it has once again prevailed in its second patent dispute with Jumpcode Genomics, Inc.
December 11, 2023
·
2 min read
Press Releases
Dx&Vx (DXVX) Partners with Over 40 Global Companies at BIO USA, “Focused Discussions on Overseas Out-Licensing Deals”
July 6, 2026
·
2 min read
1 of 55,639
Next
